Diversified Trust’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-2,510
Closed -$225K 379
2018
Q3
$225K Buy
+2,510
New +$222K 0.01% 296
2018
Q2
Sell
-2,348
Closed -$209K 338
2018
Q1
$209K Sell
2,348
-98
-4% -$9.41K 0.01% 285
2017
Q4
$255K Buy
2,446
+104
+4% +$11.7K 0.02% 246
2017
Q3
$342K Hold
2,342
0.03% 195
2017
Q2
$304K Hold
2,342
0.02% 217
2017
Q1
$291K Buy
2,342
+9
+0.4% +$1.08K 0.02% 203
2016
Q4
$270K Buy
2,333
+250
+12% +$27.8K 0.02% 198
2016
Q3
$218K Sell
2,083
-2,664
-56% -$288K 0.03% 247
2016
Q2
$468K Buy
+4,747
New +$491K 0.05% 250
2016
Q1
Sell
-2,674
Closed -$320K 429
2015
Q4
$320K Buy
+2,674
New +$309K 0.03% 313

Other funds holding CELG

Diversified Trust's CELG Position: Q4 2018 in Review

Diversified Trust sold out of Celgene Corp (CELG) in Q4 2018, closing a stake of 2,510 shares — an estimated $225K sold.

Diversified Trust first reported a position in CELG in Q4 2015 and held it in 10 quarters. The position peaked at $468K in Q2 2016. 1,317 funds tracked by Wall St. Rank hold CELG as of Q4 2018.

  • Diversified Trust reported no remaining Celgene Corp position as of Q4 2018 after selling out during the quarter.
  • Diversified Trust sold 2,510 Celgene Corp shares in Q4 2018, an estimated $225K.
  • Diversified Trust first reported a position in Celgene Corp in Q4 2015 and held it in 10 quarters.
  • Diversified Trust's Celgene Corp position peaked at $468K in Q2 2016.
  • 1,317 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2018.

Based on Diversified Trust's 13F filing for Q4 2018, filed 18 Jan 2019.